Analyst Update: Aeropostale, Inc., National Bank of Greece SA, and Pfizer Inc.

Analysts adjusted their ratings on Aeropostale Inc (ARO), National Bank of Greece (ADR) (NBG), and Pfizer Inc. (PFE)

by Griffin Kruse

Published on Feb 10, 2015 at 12:20 PM
Updated on Apr 20, 2015 at 5:32 PM

Analysts are weighing in today on teen apparel maker Aeropostale Inc (NYSE:ARO), Athens-based financial institution National Bank of Greece (ADR) (NYSE:NBG), and pharmaceutical giant Pfizer Inc. (NYSE:PFE). Here's a quick look at today's brokerage notes on ARO, NBG, and PFE.

.
  • ARO is up over 16% this morning to reach $3.07, following last night's news that the company had better-than-expected quarterly sales. In response, SunTrust Robinson and Topeka Capital both raised their price targets on the equity to $3.50, while underscoring "neutral" and "hold" ratings, respectively. On the charts, Aeropostale Inc is recovering from December's multi-year lows, with the shares advancing roughly 32.3% year-to-date. Meanwhile, sentiment in the stock's options pits is nearing a bullish climax, with ARO's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 32.58 sitting just seven percentage points away from an annual optimistic peak. However, nearly 24% of ARO's available float is sold short, which would take over five sessions to cover at average trading volumes -- suggesting a portion of this call buying could be hedging activity.

  • Hopes for a potential debt compromise between Greece and its international creditors have NBG pointing over 15% higher today to hit $1.29, but the stock has nevertheless been hit with a round of bearish brokerage notes. Specifically, Wood & Company and Barclays both cut their price targets, with the former backing a "buy" prediction and the latter reiterating the stock at "equal weight." Longer term, the shares of National Bank of Greece (ADR) are getting crushed, with the equity -- down about 28% year-to-date --touching an all-time low of $0.98 at the end of January. Not surprisingly, sentiment in NBG's options pits is extremely bearish, with its 50-day ISE/CBOE/PHLX put/call volume ratio of 0.23 ranking higher than 98% of all similar annual readings.

  • News that PFE is buying back $5 billion worth of its stock from Goldman Sachs has the company up 2.7% this morning to reach a 10-year high of $34. In response, J.P. Morgan Securities raised its price target by $1 to $36, while reiterating its "overweight" rating for the stock. The upbeat coverage is supported by Pfizer Inc.'s performance on the charts, as the equity is up over 23% since falling to an annual low of $27.51 in mid-October. Sentiment in PFE's options pits is bullish, with the stock's 10-day ISE/CBOE/PHLX call/put volume ratio of 3.72 sitting in the 62nd percentile of its annual range.

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Cannabis Stock Rally Cut Short after Downgrade
Aurora Cannabis did receive a price-target hike from Jefferies, though
Vaccines, China Trigger Roller Coaster Week for Stocks
Moderna's vaccine captured the attention of Wall Street
Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.